These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 34198775)

  • 1. Metabolic Syndrome Prevalence and Cardiovascular Risk Assessment in HIV-Positive Men with and without Antiretroviral Therapy.
    Lu WL; Lee YT; Sheu GT
    Medicina (Kaunas); 2021 Jun; 57(6):. PubMed ID: 34198775
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Metabolic Syndrome Among Antiretroviral Therapy-Naive Versus Experienced HIV-Infected Patients Without Preexisting Cardiometabolic Disorders in Western Kenya.
    Osoti A; Temu TM; Kirui N; Ngetich EK; Kamano JH; Page S; Farquhar C; Bloomfield GS
    AIDS Patient Care STDS; 2018 Jun; 32(6):215-222. PubMed ID: 29851503
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Metabolic syndrome among HIV infected patients: A comparative cross sectional study in northwestern Nigeria.
    Muhammad FY; Gezawa ID; Uloko A; Yakasai AM; Habib AG; Iliyasu G
    Diabetes Metab Syndr; 2017 Nov; 11 Suppl 1():S523-S529. PubMed ID: 28410829
    [TBL] [Abstract][Full Text] [Related]  

  • 4. An observational study of the prevalence of metabolic syndrome in treatment-experienced people living with HIV in Singapore.
    Ang LW; Ng OT; Boudville IC; Leo YS; Wong CS
    PLoS One; 2021; 16(6):e0252320. PubMed ID: 34077481
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Serum lipid levels associated with increased risk for cardiovascular disease is associated with highly active antiretroviral therapy (HAART) in HIV-1 infection.
    Koppel K; Bratt G; Eriksson M; Sandström E
    Int J STD AIDS; 2000 Jul; 11(7):451-5. PubMed ID: 10919487
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Changes in lipid profile over 24 months among adults on first-line highly active antiretroviral therapy in the home-based AIDS care program in rural Uganda.
    Buchacz K; Weidle PJ; Moore D; Were W; Mermin J; Downing R; Kigozi A; Borkowf CB; Ndazima V; Brooks JT
    J Acquir Immune Defic Syndr; 2008 Mar; 47(3):304-11. PubMed ID: 18398971
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lipid profile, cardiovascular risk factors and metabolic syndrome in a group of AIDS patients.
    Silva EF; Bassichetto KC; Lewi DS
    Arq Bras Cardiol; 2009 Aug; 93(2):113-8. PubMed ID: 19838487
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Independent predictors of metabolic syndrome in HIV-infected patients.
    Alencastro PR; Fuchs SC; Wolff FH; Ikeda ML; Brandão AB; Barcellos NT
    AIDS Patient Care STDS; 2011 Nov; 25(11):627-34. PubMed ID: 21936688
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Metabolic syndrome in HIV-infected patients from an urban, midwestern US outpatient population.
    Mondy K; Overton ET; Grubb J; Tong S; Seyfried W; Powderly W; Yarasheski K
    Clin Infect Dis; 2007 Mar; 44(5):726-34. PubMed ID: 17278068
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Study of the impact of HIV genotypic drug resistance testing on therapy efficacy.
    Van Vaerenbergh K
    Verh K Acad Geneeskd Belg; 2001; 63(5):447-73. PubMed ID: 11813503
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impact of protease inhibitor substitution with efavirenz in HIV-infected children: results of the First Pediatric Switch Study.
    McComsey G; Bhumbra N; Ma JF; Rathore M; Alvarez A;
    Pediatrics; 2003 Mar; 111(3):e275-81. PubMed ID: 12612284
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prevalence of dyslipidemia among human immunodeficiency virus infected Nigerians.
    Muhammad S; Sani MU; Okeahialam BN
    Ann Afr Med; 2013; 12(1):24-8. PubMed ID: 23480991
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prevalence of metabolic syndrome among antiretroviral-naive and antiretroviral-experienced HIV-1 infected Thai adults.
    Jantarapakde J; Phanuphak N; Chaturawit C; Pengnonyang S; Mathajittiphan P; Takamtha P; Dungjun N; Pinyakorn S; Pima W; Prasithsirikul W; Phanuphak P
    AIDS Patient Care STDS; 2014 Jul; 28(7):331-40. PubMed ID: 24914459
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Impact of Contemporary Antiretroviral Drugs on Atherosclerosis and Its Complications in People Living With HIV: A Systematic Review.
    Vemulapalli AC; Elias AA; Yerramsetti MD; Olanisa OO; Jain P; Khan QS; Butt SR
    Cureus; 2023 Oct; 15(10):e47730. PubMed ID: 38021858
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cardiovascular risk in HIV-infected individuals: A comparison of three risk prediction algorithms.
    Policarpo S; Rodrigues T; Moreira AC; Valadas E
    Rev Port Cardiol (Engl Ed); 2019 Jul; 38(7):463-470. PubMed ID: 31522936
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Elevated Framingham risk score in HIV-positive patients on highly active antiretroviral therapy: results from a Norwegian study of 721 subjects.
    Bergersen BM; Sandvik L; Bruun JN; Tonstad S
    Eur J Clin Microbiol Infect Dis; 2004 Aug; 23(8):625-30. PubMed ID: 15322938
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antiretroviral therapy in HIV-positive men is associated with increased apolipoprotein CIII in triglyceride-rich lipoproteins.
    Rimland D; Guest JL; Hernández I; Del Rio C; Le NA; Brown WV
    HIV Med; 2005 Sep; 6(5):326-33. PubMed ID: 16156880
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Metabolic syndrome in human immunodeficiency virus-infected patients.
    Duro M; Manso MC; Barreira S; Rebelo I; Medeiros R; Almeida C
    Int J STD AIDS; 2018 Nov; 29(11):1089-1097. PubMed ID: 29874955
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Adipokines levels in HIV infected patients: lipocalin-2 and fatty acid binding protein-4 as possible markers of HIV and antiretroviral therapy-related adipose tissue inflammation.
    Morieri ML; Guardigni V; Sanz JM; Dalla Nora E; Soavi C; Zuliani G; Sighinolfi L; Passaro A
    BMC Infect Dis; 2018 Jan; 18(1):10. PubMed ID: 29304747
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Metabolic syndrome and cardiometabolic risk factors among indigenous Malaysians.
    Aghakhanian F; Wong C; Tan JSY; Yeo LF; Ramadas A; Edo J; Hoh BP; Khalid BAK; Phipps ME
    Public Health; 2019 Nov; 176():106-113. PubMed ID: 30509859
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.